A tilapia farm experiencing endemic streptococcosis was selected to study the effect of vaccination with a feed-based vaccine on naturally ocurring streptococcosis. A total of 9000 red tilapia, Oreochromis niloticus Â Oreochromis mossambicus of 100 ± 20 g were divided into 9 cages. Fish of Group 1 in cages 1, 2 and 3 were not vaccinated. Group 2 in cages 4, 5 and 6 were vaccinated on days 0 and 14 (single booster) while Group 3 in cages 7, 8 and 9 were vaccinated on days 0, 14 and 42 (double booster). Vaccination was done by oral administration of the feed-based bacterin vaccine at 4% bodyweight. Samples of serum for antibody study and the brain, eyes and kidney for bacterial isolation were collected at 14-day intervals. The study was carried out during the critical months between April and June. Following vaccination and booster, there was significant (p < 0.05) increase in the antibody levels in all vaccinated groups from week 1 that reached the peak at week 3 before declining gradually until week 6. However, second booster on week 6 significantly (p < 0.05) increased the antibody level that remained high until the end of the 16-week study period (double booster). Streptococcus agalactiae was isolated at the start of the experiment (day 0) at an average of 10 ± 5.0% of the sampled fish. In week 4, the isolation rate was 13 ± 5.7% but increased to 18 ± 7.6% in week 8, to 25 ± 10.0% in week 10, to 28 ± 5.8% in week 12 and 25 ± 7.3% in week 14. The average isolation rate was 28 ± 7.2%, 18 ± 7.1% and 13 ± 8.2% of the fish sampled from unvaccinated, single booster and double booster groups, respectively. At the end of the study period, the survival rate was 45.2 ± 2.45% for unvaccinated, 65.3 ± 4.8% for single booster and 75.1 ± 2.1% for double booster groups. Vaccinating fish in endemic farm might not eliminate the disease but was able to significantly improve the survival rate.
Introduction
Streptococcosis is one of the major contributors to the staggering losses in aquaculture industry. It is usually caused by two Streptococcus species; S. agalactiae and S. iniae. Most outbreaks of streptococcosis in tilapia farms occur following introduction of the organisms via tilapia fry [1] and were observed during the hot months that enhanced the pathogenicity of Streptococcus species to tilapia, leading to acute and extensive mortality [2e4] . On the other hand, some tilapia farms are facing endemic streptococcosis causing consistently low death rates that eventually lead to substantial cumulative mortality [5] .
Vaccination is a suitable method to control streptococcosis in fish [6] . A more practical route of vaccination for tilapia farm is the oral administration as there is no direct contact between handler and fish, and no specific technical skill is needed to apply the vaccine to the fish [7] . However, oral vaccination resulted in lower efficacy and shorter period of protection that lasted 6 weeks [7] . Therefore, a vaccination regimen is needed to ensure that vaccination protects fish during the 3-month susceptible hot period [6] . This paper describes the duration of immune response and the effect of a feed-based bacterin vaccine on the incidence of streptococcosis in a farm experiencing endemic streptococcosis.
Materials and methods

Study site
The vaccination trial was conducted in a private farm located at Kenyir Lake, a man-made lake located in the state of Terengganu in the east coast of peninsular Malaysia. The selected farm was one of the private farms that had a history of endemic streptococcosis resulting in cumulatively high mortality, particularly during the hot months of April to July. Tilapia was the main fish cultured other than some catfish (Clarius gariepinus) and barramundi (Lates calcarifer).
The fish
A total of 9000 red tilapia, Oreochromis niloticus Â Oreochromis mossambicus with an average bodyweight of 100 ± 20 g were selected for the study. The fries were initially acquired from a local hatchery and were reared in hapa net for a month. Once they reached the suitable size, they were transferred into cages in the farm. The selected fish were divided evenly into 9 floating cages of 4 m length Â 4 m width Â 4 m depth with an average stocking density of 1000 fish per cage or 16 fish/m 3 . They were fed commercial fish pellet at 4% bodyweight. Prior to the start of the experiment, 30 fish were randomly selected and sampled for bacteria and parasites to ensure the health status of the fish.
Bacterial strain
Streptococcus agalactiae strain TP 749B was used in this study. The isolate was obtained from a streptococcosis outbreak involving cage-cultured red tilapia in 2007 at Pahang River, Malaysia. Prior to the experiment, the stock culture was subjected to several cycles of re-virulence by introducing the isolate into red tilapia via intraperitoneal injections.
Preparation of formalin-killed bacteria and feed-based vaccine
The formalin-killed bacteria was prepared according to the method described earlier [7] . The selected S. agalactiae (TP 749B) was cultured on 5% blood agar and incubated at 30 C for 24 h. Propagation of S. agalactiae was then done by inoculating 10 colonies into Brain Heart Infusion Broth (BHIB) before incubated in shaker incubator at 150 rpm at 30 C for 24 h. The bacterial concentration was determined using the standard plate count technique. The cells of S. agalactiae were then harvested by centrifugation (6000Âg, 10 min) and washed with phosphatebuffered saline (PBS). The bacterial pellet was then re-suspended in PBS and further washed for 3 times. Buffered formalin was then added to a final concentration of 0.5% formalin before the mixture was kept overnight at 4 C to kill the bacteria. Next, the bacteria were washed repeatedly for 5 times with PBS and centrifugation to remove the formalin residue. Finally, the bacteria suspension was plated on blood agar (BA) to check whether the bacteria were completely killed and stored at 4 C. Then, the bacterial cells were washed again with PBS with centrifugation (6000Âg, 10 min) for 3 times. The formalin-killed bacteria were resuspended in sterile PBS to obtain the final bacterial concentration of 6.7 Â 10 7 CFU/mL. The suspension was streaked on blood agar and incubated for 24 h at 37 C to ensure that all S. agalactiae were killed and no contamination. To improve the immune response, Freund's incomplete adjuvant (FIA) was added to a final concentration of 10% before it was thoroughly mixed with pelletted feed to give a final concentration of 10 6 cells/kg of feed [7] .
Experimental design
The vaccination trial was carried out for a period of 16 weeks during the critical months of April to July [8] . A day before the feedbased vaccine administration, the fish were not fed to ensure maximum oral feed-vaccine uptake. At the start of the experiment, the fish were divided into 3 groups. Group 1 consisted of cages 1, 2 and 3 were given a normal commercial feed without the vaccine as control unvaccinated group. Group 2 consisted of cages 4, 5 and 6 were fed the feed-based vaccine on days 0 and 14 (single booster) while Group 3 consisted of cages 7, 8 and 9 were fed the same feedbased vaccine on days 0, 14 and 42 (double booster). The feed containing the vaccine was given at 4% bodyweight to ensure that each fish was exposed to at least 10 3 killed S. agalactiae/g of feed.
Other husbandry and feeding practices adopted in the farm were not disturbed. On day 0 and at 14-day interval thereafter, serum and organ samples (brain, eye and kidney) were collected for antibody determination and bacterial isolation, respectively. At the same interval, water quality parameters were monitored throughout the experiment by YSI Professional Plus (Yellow Spring Instrument, USA) until the end of the 16-week trial period.
All fish mortalities and abnormal signs were recorded throughout the whole period of experimentation. The rate of survival was calculated while the approximate final total fish weight was estimated based on the reported daily weight gain for red tilapia [9] . The experiment was approved by the Institutional Animal Care and Use Committee, Universiti Putra Malaysia (IACUC no. R038/2013).
Bacterial identification
Samples for bacterial isolation were cultured on blood agar and incubated at 37 C for 18e24 h. The dominant bacterial colonies were sub-cultured to obtain the pure colonies. The isolates were then proceeded to Gram staining, oxidase and catalase tests. Catalase negative Gram-positive cocci were subjected to API 20 STREP bacteria identification kit (BioMerieux, France), while catalase positive Gram-positive cocci were subjected to API STAPH (BioMerieux, France). Oxidase negative Gram-negative isolates were subjected to API 20E while those showing oxidase positive were subjected to API 20NE (BioMerieux, France). The colour coded API identification was referred to the APILAB PLUS program (BioMerieux, France) for species and genus determination of the isolates. All isolates identified as S. agalactiae by API system were confirmed by PCR [10] .
Enzyme-linked immunosorbent assay (ELISA)
All serum samples were subjected to indirect ELISA according to the method previously described [11, 12] with minor modifications.
Flat-bottom microtitre plates were coated with 100 mL coating antigen and were left overnight at 4 C before washed twice with phosphate buffer saline þ0.05% Tween 20 (PBST). Then 200 mL of 2% bovine serum albumin (BSA) diluted in PBST was added and incubated at 37 C for 1 h. This was followed by adding 100 mL of 1:1000 serum diluted in PBST into the reaction well and incubated at 37 C for 1 h. The microtitre plate was then washed three times with PBST to wash off the unbound antibody. Next, 100 mL of 1:10,000 diluted goat anti-tilapia was added and incubated again for 1 h at 37 C.
After washed three times with PBST, 100 mL conjugated rabbit antigoat IgM-horseradish peroxidise (Nordic, Netherland) diluted to 1:10,000 was added into the reaction well and incubated. After washed for three times with PBST, bound conjugate were detected by adding 100 mL of TMB One substrate solution (Promega, USA) and incubated at 37 C for 30 min before the reaction was stopped with 0.2 mol/L sulphuric acid. The colour intensity was determined by iMark™ Microplate Reader (Bio-Rad, USA) at 450 nm wavelength.
Statistical analysis
The significance value of this experimental results were calculated by using one way analysis of variance (ANOVA) employed by Tukey HSD in Statistix 9 software (Analytical software, USA). The results were considered as significant at p < 0.05.
Results
Serum antibody responses
Prior to the vaccine administration, all groups showed insignificant (p > 0.05) differences in the antibody level against S. agalactiae and was below the cut-off value. Following vaccination, both vaccinated groups showed significant (p < 0.05) increase in the antibody level that reached peak at week 4 but gradually declined thereafter to reach the non-protective cut-off value by week 10 in the single booster group (Fig. 1) . However, following another booster at week 6 (double booster group), the antibody level showed significant (p < 0.05) increase to reach peak at week 8 before gradually reduced insignificantly (p > 0.05) thereafter but remained above the cut-off value until the end of the experimental period at week 16 ( Fig. 1) . Therefore, double booster resulted in significantly (p < 0.05) high antibody level above the cut-off value throughout the 16-week study period.
Isolation of Streptococcus agalactiae
Streptococcus agalactiae was successfully isolated from the sampled fish as early as week 0 at an average rate of 10 ± 5.0%. In week 4, the average rate of isolation was 13 ± 5.7% (p > 0.05 compared with week 0), week 8 was 18 ± 7.6% (p > 0.05), week 10 was 25 ± 10.0% (p < 0.05), week 12 at 28 ± 5.8% (p < 0.05) and week 14 with 25 ± 7.3% (p < 0.05) (Fig. 1) . The overall incidence of S. agalactiae throughout the study period was 28 ± 7.2%, 18 ± 7.1% (p < 0.05 compared with control group) and 13 ± 8.2% (p < 0.05) for Groups 1, 2 and 3, respectively (Table 1) . Other isolated potential pathogenic bacteria included Plesiomonas shigelloides, Enterobacter cloacae, Edwardsiella sp. and Staphylococcus sp. They were isolated from the kidney of fish of all groups.
Rate of survival
At the end of 16-week study period, the fish survival rate was 45.2 ± 2.3%, 65.3 ± 4.8% (p < 0.05 compared with control) and 75.1 ± 2.0% (p < 0.05) for the control, single, double booster groups with approximate total fish weight of 347 kg, 481 kg and 553 kg, respectively. Table 2 summarises the water quality parameters of Kenyir Lake during the study. Most parameters were within the acceptable level except the water temperature (29.65 ± 1.29 C), water clarity (335.1 ± 41.1 cm) and pH (7.35 ± 0.51) that might predispose fish to infections. Different superscripts represent significant (p < 0.05) differences within the same column. e,f Different superscript represent significant (p < 0.05) differences within the same row.
Water quality
Discussion
Streptococcosis caused by S. agalactiae frequently leads to high mortality and huge economic loss [2e4, 13, 14] . However, inapparent S. agalactiae infections in adult/commercial tilapia have been reported leading to endemic disease among tilapia that results in high cumulative mortality [6, 15] . Similar low-grade infection by S. agalactiae was observed throughout this study that lead to a substantial cumulative mortality especially in the control group. Therefore, control of streptococcosis via vaccination is deemed crucial [5] especially when commercial vaccines are available for several species of fish including tilapia [16] . Furthermore, usage of vaccines have significant positive impact on the reduced usage of antibiotics [17] .
Following an experimental trial, a newly developed feed-based streptococcosis bacterin vaccine provided an efficacy of 70% survival against challenge of oral-vaccinated tilapia [7] . The single booster regimen used in that study provided short-term antibody response and protection. Since booster dose can enhance and extend protection for a period of 3 months [18] , a double booster vaccination regimen used in this study resulted in longer period of protection and 70% survival rate. The results of this study are in agreement when between 65 and 75% survival were recorded following administration of this vaccine in an experimental streptococcosis [19] . The slightly low efficacy of the feed-based vaccine is expected since in most cases, only limited protection and shorter duration can be obtained following oral administration of vaccines [20] . Thus, double booster in this study was able to prolong the immunity throughout the 3-month critical period, reduce the mortality and enhance final fish weight.
Under natural farm condition, multiple infections as observed in this study are common. The multiple infections involve several species of bacteria [21] , parasitic and bacterial diseases [22] or bacterial and viral infections [23] . A single infectious agent frequently results in death-loss that is relatively small [22] compared with the death-loss in cultured fish farms due to multiple pathogenic infections [23] . Similarly, this study revealed slightly higher death rate compared with the incidence rate of S. agalactiae likely following death due to other pathogens or environmental factors.
In conclusion, vaccinating tilapia with feed-based bacterin vaccine in farms experiencing endemic streptococcosis is able to reduce the incidence of streptococcosis to 13% and improve the rate of survival to 75%. 
